Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
LONDON (Alliance News) - FTSE 100 pharma company GlaxoSmithKline PLC said Friday a European Medicines Agency committee has recommended its asthma drug Nucala for patients between six and 17 years
Read moreLONDON (Alliance News) - Former HSBC Holdings PLC Finance Director Iain Mackay is currently in the running to become chief financial officer of FTSE 100-listed pharmaceutical giant GlaxoSmithKline
Read more
(Sharecast News) - Beazley: Berenberg upgrades to buy with a target price of 640p.
Read moreLONDON (Alliance News) - Stock prices in London were flat at midday as investors absorbed Thursday's bounty of company results.Gains for reporting firms British America Tobacco,
Read moreLONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------British up a
Read moreLONDON (Alliance News) - GlaxoSmithKline PLC said Thursday an advisory panel of US Food & Drug Administration has recommended against approval of mepolizumab for the treatment of chronic a of
Read more(Sharecast News) - GlaxoSmithKline's application to market a new biologic drug for chronic obstructive pulmonary disease has been rejected by the advisory board of the US medical watchdog, though the company remains confident in the drug as a COPD treatment.
Read moreLONDON (Alliance News) - GlaxoSmithKline said Wednesday it is taking new approach to research & development by partnering with genetic profiling company 23andMe Inc, as it reported a strong of
Read moreLONDON (Alliance News) - GlaxoSmithKline PLC on Wednesday posted a rise in first half profit due to strong performance of its new shingles drug.In the first half ended June 30, the pretax a
Read moreLONDON (Alliance News) - Stocks continued to trade mostly lower at midday on Wednesday, with focus on a meeting between the European Commission president and US president amid escalating global trade
Read more(Sharecast News) - GlaxoSmithKline has invested $300m (£228m) in 23andMe, a Silicon Valley gene-testing company, as the UK drugs giant looks to genetics to improve growth in its pharmaceuticals division.
Read more(Sharecast News) - Glaxosmithkline's ViiV Healthcare joint venture reported positive results from trials of two of its key HIV treatments on Tuesday.
Read moreLONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday its joint venture ViiV Healthcare's two-drug regimen for the treatment of HIV met its primary endpoint in two studies.The FTSE
Read moreLONDON (Alliance News) - Sentiment in Europe was soft at the start of the week, with the FTSE 100 lower at midday on Monday after US President Trump switched his focus to Iran from his tariff threats
Read moreLONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - up 0.5%. The pharmaceutical company is splitting
Read more
Last checked at